Shingo Nakamoto

2.7k total citations
107 papers, 1.6k citations indexed

About

Shingo Nakamoto is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Shingo Nakamoto has authored 107 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hepatology, 62 papers in Epidemiology and 14 papers in Infectious Diseases. Recurrent topics in Shingo Nakamoto's work include Hepatitis C virus research (62 papers), Liver Disease Diagnosis and Treatment (47 papers) and Hepatitis B Virus Studies (42 papers). Shingo Nakamoto is often cited by papers focused on Hepatitis C virus research (62 papers), Liver Disease Diagnosis and Treatment (47 papers) and Hepatitis B Virus Studies (42 papers). Shingo Nakamoto collaborates with scholars based in Japan, United States and China. Shingo Nakamoto's co-authors include Osamu Yokosuka, Tatsuo Kanda, Shuang Wu, Masato Nakamura, Fumio Imazeki, Makoto Arai, Xia Jiang, Yuki Haga, Keiichi Fujiwara and Reina Sasaki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shingo Nakamoto

104 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingo Nakamoto Japan 23 1.0k 844 245 222 151 107 1.6k
Masaru Enomoto Japan 27 1.6k 1.5× 1.6k 1.9× 441 1.8× 160 0.7× 110 0.7× 165 2.6k
Michel Doffoël France 23 1.4k 1.3× 1.1k 1.3× 129 0.5× 86 0.4× 134 0.9× 70 1.9k
Myoung Kuk Jang South Korea 23 1.0k 1.0× 1.1k 1.3× 312 1.3× 102 0.5× 149 1.0× 75 2.0k
Pascal Lapierre Canada 24 1.0k 1.0× 856 1.0× 325 1.3× 112 0.5× 43 0.3× 47 1.8k
Hiroki Sakaguchi Japan 18 742 0.7× 1.1k 1.3× 264 1.1× 86 0.4× 83 0.5× 77 1.5k
Fusao Ikeda Japan 26 1.5k 1.4× 1.3k 1.5× 320 1.3× 98 0.4× 116 0.8× 115 2.3k
Zoe Mariñó Spain 21 2.1k 2.0× 1.9k 2.3× 152 0.6× 155 0.7× 62 0.4× 90 2.5k
Jean‐Charles Duclos‐Vallée France 29 1.7k 1.6× 1.5k 1.7× 220 0.9× 275 1.2× 71 0.5× 116 2.5k
Christoph Welsch Germany 23 1.5k 1.4× 1.2k 1.5× 385 1.6× 431 1.9× 32 0.2× 89 2.1k
Naohide Tanaka Japan 18 785 0.8× 669 0.8× 83 0.3× 89 0.4× 82 0.5× 73 1.2k

Countries citing papers authored by Shingo Nakamoto

Since Specialization
Citations

This map shows the geographic impact of Shingo Nakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Nakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Nakamoto more than expected).

Fields of papers citing papers by Shingo Nakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Nakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Nakamoto. The network helps show where Shingo Nakamoto may publish in the future.

Co-authorship network of co-authors of Shingo Nakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Nakamoto. A scholar is included among the top collaborators of Shingo Nakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Nakamoto. Shingo Nakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanda, Tatsuo, Tian‐Cheng Li, Masaharu Takahashi, et al.. (2024). Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatology Research. 54(8). 1–30. 5 indexed citations
2.
Kanda, Tatsuo, Reina Sasaki, Koji Ishii, et al.. (2023). Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan. Hepatology Research. 54(1). 4–23. 6 indexed citations
3.
Nakamoto, Shingo, Keita Ogawa, Junjie Ao, et al.. (2023). Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma. World Journal of Virology. 12(3). 209–220. 3 indexed citations
4.
Saito, Kazuki, Shingo Nakamoto, Ryosuke Muroyama, et al.. (2020). A Novel Chiral Compound CCL441 Induces Mitotic Arrest and Apoptosis in Hepatoblastoma HepG2 Cells. 5(1). 1 indexed citations
5.
Kanda, Tatsuo, Shingo Nakamoto, Mitsuhiko Moriyama, et al.. (2018). Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression. International Journal of Medical Sciences. 15(11). 1153–1159. 17 indexed citations
6.
Jiang, Xia, Tatsuo Kanda, Yuki Haga, et al.. (2017). Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication. Experimental and Therapeutic Medicine. 13(6). 3305–3308. 17 indexed citations
7.
Ogasawara, Sadahisa, Tetsuhiro Chiba, Yoshihiko Ooka, et al.. (2017). Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment. Investigational New Drugs. 36(2). 332–339. 42 indexed citations
8.
Sasaki, Reina, Tatsuo Kanda, Masato Nakamura, et al.. (2016). Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells. PLoS ONE. 11(1). e0146314–e0146314. 16 indexed citations
9.
Sasaki, Reina, Tatsuo Kanda, Shuang Wu, et al.. (2015). Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver. Biochemical and Biophysical Research Communications. 464(4). 1192–1195. 10 indexed citations
10.
Kanda, Tatsuo, Shingo Nakamoto, Masato Nakamura, et al.. (2014). Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection. Journal of Clinical and Translational Hepatology. 2(1). 1–6. 10 indexed citations
11.
Nakamura, Masato, Tatsuo Kanda, Shingo Nakamoto, et al.. (2013). No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV. PLoS ONE. 8(12). e81312–e81312. 30 indexed citations
12.
Kanda, Tatsuo, Shingo Nakamoto, Makoto Arai, et al.. (2013). Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient. Clinical Journal of Gastroenterology. 6(2). 160–163. 3 indexed citations
13.
Wu, Shuang, Tatsuo Kanda, Shingo Nakamoto, et al.. (2013). Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific Region. PLoS ONE. 8(9). e73615–e73615. 27 indexed citations
14.
Kanda, Tatsuo, Keizo Kato, Akihito Tsubota, et al.. (2013). Platelet count and sustained virological response in hepatitis C treatment. World Journal of Hepatology. 5(4). 182–182. 11 indexed citations
15.
Nakano, Masahito, Takumi Kawaguchi, Shingo Nakamoto, et al.. (2013). Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. Oncology Reports. 30(5). 2049–2055. 4 indexed citations
16.
Kanda, Tatsuo, Shuang Wu, Tomoko Kiyohara, et al.. (2012). Interleukin-29 Suppresses Hepatitis A and C Viral Internal Ribosomal Entry Site-Mediated Translation. Viral Immunology. 25(5). 379–386. 16 indexed citations
17.
Kanda, Tatsuo, Shuang Wu, Shingo Nakamoto, et al.. (2012). Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B. International Journal of Medical Sciences. 9(1). 27–32. 8 indexed citations
18.
Miyamura, Tatsuo, Koji Ishii, Tatsuo Kanda, et al.. (2011). Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure. Hepatology Research. 42(3). 248–253. 18 indexed citations
19.
Masaki, Takahiro, Asako Murayama, Tsubasa Munakata, et al.. (2011). Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. Biochemical and Biophysical Research Communications. 410(3). 404–409. 6 indexed citations
20.
Nakamoto, Shingo, Fumio Imazeki, Kenichi Fukai, et al.. (2009). Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. Journal of Hepatology. 52(1). 72–78. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaru Enomoto Breakdown of academic impact, for papers by Michel Doffoël Breakdown of academic impact, for papers by Myoung Kuk Jang Breakdown of academic impact, for papers by Pascal Lapierre Breakdown of academic impact, for papers by Hiroki Sakaguchi Breakdown of academic impact, for papers by Fusao Ikeda Breakdown of academic impact, for papers by Zoe Mariñó Breakdown of academic impact, for papers by Jean‐Charles Duclos‐Vallée Breakdown of academic impact, for papers by Christoph Welsch Breakdown of academic impact, for papers by Naohide Tanaka
Rankless by CCL
2026